Campbell & CO Investment Adviser LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1353570 BALTIMORE, MD

Position in TMO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,660,915

+$672,112 QoQ

Shares Held

7,448

+44.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $54,655,619 across 18 Diagnostics & Research names. TMO ranks #6 (6.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	A	Agilent Technologies, Inc.	89,159	$10,162,342
2	DHR	Danaher Corp /De/	33,267	$6,307,423
3	WAT	Waters Corp /De/	16,002	$4,765,395
4	GH	Guardant Health, Inc.	48,547	$4,484,286
5	IDXX	Idexx Laboratories Inc /De	7,772	$4,367,009
6	TMO	Thermo Fisher Scientific Inc. This page	7,448	$3,660,915
7	CSTL	Castle Biosciences Inc	148,824	$3,653,629
8	VCYT	Veracyte, Inc.	106,443	$3,428,529

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,660,915	7,448	+44.4%	Shares	Sole	2026-05-15
2025-12-31	$2,988,803	5,158	+78.4%	Shares	Sole	2026-02-12
2025-06-30	$1,172,590	2,892	-39.5%	Shares	Sole	2025-08-07
2024-06-30	$2,643,893	4,781	+564.0%	Shares	Sole	2024-08-13
2023-12-31	$382,168	720	+9.6%	Shares	Sole	2024-02-13
2023-06-30	$342,789	657	+64.2%	Shares	Sole	2023-08-11
2021-09-30	$228,532	400	-42.9%	Shares	Sole	2021-11-10
2021-06-30	$353,129	700	+16.7%	Shares	Sole	2021-08-11
2021-03-31	$273,828	600	-60.0%	Shares	Sole	2021-05-14
2020-12-31	$698,670	1,500	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.